German Center for Neurodegenerative Diseases
| German Center for Neurodegenerative Diseases (DZNE) |
|
|---|---|
|
|
| purpose | research |
| Chair: | Pierluigi Nicotera (CEO) |
| Establishment date: | April 3, 2009 |
| Number of members: | 9 locations |
| Employee | 900 |
| Seat : | Bonn |
| Website: | www.dzne.de |
The German Center for Neurodegenerative Diseases e. V. (DZNE) is a non-university research facility for neurodegenerative diseases in all their facets. It is one of six German centers for health research that were set up by the Federal Ministry of Education and Research to “combat” the most important common diseases . It is one of the 18 research institutions of the Helmholtz Association of German Research Centers .
history
In 2007 the federal government decided to set up the DZNE at a closed meeting in Meseberg . In 2017, the new building was opened on Bonn's Venusberg . The state of North Rhine-Westphalia bore 77% of the construction costs, the federal government the remaining 23%. It is also a research building, headquarters of the administration and the board of directors. Pierluigi Nicotera is the founding director .
Locations
There are ten locations:
- Berlin focuses its work on the transmission mechanisms at the synaptic gap and network activity
- Bonn is the administrative headquarters of the DZNE and deals with basic research , clinical studies and population studies
- Dresden is researching how aging processes in the brain can be avoided
- Göttingen analyzes how Parkinson's disease develops
- Magdeburg investigates ways to improve learning and memory
- Munich , where Alois Alzheimer also did his science, researches the risk factors of dementia
- Rostock / Greifswald examines the consequences of demographic change
- Tübingen in basic neuro research
- Ulm deals with rare neurodegenerative diseases such as amyotrophic lateral sclerosis
- Witten has care concepts for patients to focus
financing
The DZNE is funded with 90% by the Federal Ministry of Education and Research and 10% by the respective DZNE host countries. The basic funding amounts to 81 million euros per year.
price
Since 2011, the association with the Hartwig Piepenbrock Cultural Foundation has awarded the Hartwig Piepenbrock-DZNE Prize for research in the field of neurodegenerative diseases and aging every two years , which is endowed with € 60,000. The first prize winner was Konrad Beyreuther . In 2013, the prize amount was increased once to € 100,000, the prize was shared by Adriano Aguzzi and Charles Weissmann for their prion research. In 2015 John Hardy was recognized for his work on Alzheimer 's. Heiko Braak was honored in 2017 for his fundamental research on Parkinson's and Alzheimer's. Christian Haass received the award in 2019 for his work on the molecular mechanisms of Alzheimer's disease .
Web links
swell
- ↑ https://www.dzne.de/ueber-uns/vorstand/
- ↑ Resonator Podcast of the Helmholtz Association : Dementia Research at the DZNE (Volume 4, May 24, 2013)
- ↑ Resonator podcast of the Helmholtz Association : (Dementia) Care Management (episode 101, February 17, 2017)
- ↑ DZNE About us
- ↑ Chancellor opens Center for Dementia Research WDR on March 15, 2017
- ↑ Verena Mäusbacher: Room for Research and Science General-Anzeiger from September 14, 2011
- ↑ Birgit Hibbeler: German Dementia Center in Bonn: “That is huge, what is being created here.” Deutsches Ärzteblatt 2008; 105 (44): A-2319 / B-1982 / C-1930
- ↑ https://www.dzne.de/ueber-uns/standorte/
- ↑ Philipp Königs: On the trail of the reasons for dementia General-Anzeiger of March 3, 2016
- ↑ Brigitte Osterath: Proteins that make you sick Deutsche Welle of September 24, 2013
- ↑ Neue Osnabrücker Zeitung : Piepenbrock DZNE Prize goes to John Hardy on August 5, 2015
- ↑ Doctors newspaper : Award for research on Parkinson's and Alzheimer's from August 28, 2017
- ↑ General-Anzeiger Bonn : Biochemist receives award for Alzheimer's research from October 1, 2019